Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer

Recruiting now · Not applicable

Conditions studied: Pediatric Cancer, Survivorship

In brief

Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in AYA patients with and surviving childhood cancer.

Key facts

Study ID

NCT05524610

Run by

University of Colorado, Denver

People needed

205

Starts

2023-02-14

Expected to finish

2027-06-30

Last updated by the study team

2026-05-06

Who can join

Age: 15 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• In order to be eligible to participate in this study, an individual must meet all of the following criteria:
• Provision to sign and date the consent form.
• Stated willingness to comply with all study procedures and be available for the duration of the study.
• Be aged 15-24 years old at the time of enrollment
• Patients with or surviving of cancer (must be found in the International Classification of Diseases for Oncology (ICD-O) and have a behavior code ≥2)
• Must have received cancer-directed therapy with at least one of the following:
• Chemotherapy: any anticancer drug to treat the cancer diagnosis including immunotherapy
• Radiotherapy: any radiotherapy to treat the cancer diagnosis
• Surgery: any surgery to remove cancer including partial or total resections. Biopsies are not considered surgery.
• Cancer must have been diagnosed before the age of 18 years
• Patient must have an appointment at one of four clinical sites: CHCO HOPE Survivorship Program, CHCO Oncology Clinic, CHCO Neuro-Oncology Clinic, Seattle Children's Hospital Survivorship Program

You may not qualify if…

• An individual who meets any of the following criteria will be excluded from participation in this study:
• Unable to read and speak English
• Patients who did not receive cancer-directed therapy
• Insufficient cognitive functioning to complete study measures, as determined by patient's
• Participation in intervention development
• Patient is at end of life or on hospice, as determined by primary oncologist
• Patients who did not undergo sexual function screening within 1 month of being due will be excluded from implementation outcomes measurement
• Patient is at end of life or on hospice, as determined by primary oncologist

Where it is running

• Childrens Hospital Colorado — Aurora, Colorado, United States (enrolling)
• University of Colorado Hospital — Aurora, Colorado, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.